Professor Gregory Monteith
Professor

Gregory Monteith

Email: 
Phone: 
+61 7 334 61855

Background

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy and Pharmaceutical Sciences at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Availability

Professor Gregory Monteith is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • calcium regulation in disease and cell signalling

    Our current projects are focussed on the study of a variety of calcium transporters in disease for the identification of novel drug targets. PhD and Post-doctoral opportunities may be available, contact - gregm@uq.edu.au and see the "supervision availability" link.

  • High throughput calcium assays for biomolecular screening and cancer research

    Our laboratory uses a suite of genetically encoded calcium indicators in FLIPR and high content imaging systems, allowing high throughput measurement of intracellular calcium in living cells. PhD and Post-doctoral opportunities may be available, contact - gregm@uq.edu.au and see the "supervision availability" link.

Search Professor Gregory Monteith’s works on UQ eSpace

432 works between 1992 and 2026
All (432) Book (1) Journal Article (141) Other Outputs (1) Conference Publication (282) Book Chapter (7)

361 - 380 of 432 works

2003

Journal Article

Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurones

Hemstapat, K., Monteith, G. R., Smith, D. and Smith, M. T. (2003). Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurones. Anesthesia & Analgesia, 97 (2), 494-505. doi: 10.1213/01.ANE.0000059225.40049.99

Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurones

2003

Journal Article

Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability Steven A. Smith, Gregory R. Monteith, Nicola A. Holman, Jodie A. Robinson, Fion

Smith, Steven A., Monteith, Gregory R., Holman, Nicola A., Robinson, Jodie A., May, Fiona J. and Roberts-Thomson, Sarah J. (2003). Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability Steven A. Smith, Gregory R. Monteith, Nicola A. Holman, Jodie A. Robinson, Fion. Journal of Neuroscience Research, 72 (6), 747-755. doi: 10.1002/jnr.10613

Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability Steven A. Smith, Gregory R. Monteith, Nicola A. Holman, Jodie A. Robinson, Fion

2003

Conference Publication

Generation of a tetracycline-regulated stable MCF-7 breast cancer cell line expressing human peroxisome proliferator-activated receptor alpha

Holman, N. A., Davis, B.J., Monteith, G. R., Roberts-Thomson, S. J. and Robinson, J. A. (2003). Generation of a tetracycline-regulated stable MCF-7 breast cancer cell line expressing human peroxisome proliferator-activated receptor alpha. ASCEPT 2003, Sydney, NSW, Australia, December, 2003. Melbourne, Vic, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).

Generation of a tetracycline-regulated stable MCF-7 breast cancer cell line expressing human peroxisome proliferator-activated receptor alpha

2003

Conference Publication

Environmental pollutant phthalate esters: Investigation into possible activation of peroxisome proliferator-activated receptor ? (PPAR?)

Gopisetty Venkata, N., Robinson, J. A., Davis, B.J., Monteith, G. R. and Roberts-Thomson, S. J. (2003). Environmental pollutant phthalate esters: Investigation into possible activation of peroxisome proliferator-activated receptor ? (PPAR?). ASCEPT 2003, Sydney, NSW, Australia, December, 2003. Melbourne, Vic, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).

Environmental pollutant phthalate esters: Investigation into possible activation of peroxisome proliferator-activated receptor ? (PPAR?)

2003

Conference Publication

Cell adhesion molecules mediate adhesion between immune cells and sensory neurones invitro: A role in inflammatory hyperalgesia

Cabot, P. J., Hermanussen, S. F., Tang, L.W.C. and Monteith, G. R. (2003). Cell adhesion molecules mediate adhesion between immune cells and sensory neurones invitro: A role in inflammatory hyperalgesia. Annual Queensland Health and Medical Scientific Meeting, Brisbane, Qld, Australia, 25-26 November, 2003. Brisbane, Qld, Australia: Queensland Health.

Cell adhesion molecules mediate adhesion between immune cells and sensory neurones invitro: A role in inflammatory hyperalgesia

2003

Book Chapter

Recent developments in calcium signaling

Monteith, G. R. (2003). Recent developments in calcium signaling. Molecular Pathomechanisms and New Trends in Drug Research. (pp. 114-119) edited by G. Keri and I. Toth. London & New York: Taylor & Francis.

Recent developments in calcium signaling

2003

Conference Publication

Generation of a stable MCF-7 cell line expressing tetracycline-regulated antisense towards the plasma membrane calcium

Lee, W.J., Robinson, J. A., Holman, N. A., McCall, M., Roberts-Thomson, S. J. and Monteith, G. R. (2003). Generation of a stable MCF-7 cell line expressing tetracycline-regulated antisense towards the plasma membrane calcium. ASCEPT 2003, Sydney, NSW, Australia, December, 2003. Melbourne, Vic, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).

Generation of a stable MCF-7 cell line expressing tetracycline-regulated antisense towards the plasma membrane calcium

2003

Journal Article

The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones

Hemstapat, K., Smith, S. A., Monteith, G. R. and Smith, M. T. (2003). The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones. Pharmacology & Toxicology, 93 (4), 197-200. doi: 10.1034/j.1600-0773.2003.930408.x

The neuroexcitatory morphine metabolite, morphine-3-glucuronide (M3G), is not neurotoxic in primary cultures of either hippocampal or cerebellar granule neurones

2003

Conference Publication

Peroxisome proliferator-activated receptors (PPAR) and breast cancer

Roberts-Thomson, S. J., Robinson, J. A., Faddy, H. M., Holman, N. A., Davis, B.J., Gopisetty Venkata, N., Suchanek, K. M., May, F. J., Lee, W. J. and Monteith, G. R. (2003). Peroxisome proliferator-activated receptors (PPAR) and breast cancer. Annual Queensland Health & Medical Scientific Meeting 2003, Brisbane, Qld, Australia, 25-26 November, 2003. Brisbane, Qld, Australia: Queensland Health.

Peroxisome proliferator-activated receptors (PPAR) and breast cancer

2003

Conference Publication

Characterisation of peroxisome proliferator-activated receptor a and its effects on MCF-7 breast cancer cells

Faddy, H. M., Robinson, J. A., Holman, N. A., Davis, B.J., Monteith, G. R. and Roberts-Thomson, S. J. (2003). Characterisation of peroxisome proliferator-activated receptor a and its effects on MCF-7 breast cancer cells. ASCEPT 2003, Sydney, NSW, Australia, December, 2003. Melbourne, Vic, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).

Characterisation of peroxisome proliferator-activated receptor a and its effects on MCF-7 breast cancer cells

2002

Journal Article

Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines.

Lee, W. J., Roberts-Thomson, S. J., Holman, N. A., May, F. J., Lehrbach, G. M. and Monteith, G. R. (2002). Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines.. Cellular Signalling, 14 (12), 1015-1022. doi: 10.1016/S0898-6568(02)00049-9

Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines.

2002

Journal Article

Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231

Suchanek, Kate M., May, Fiona J., Robinson, Jodie A., Lee, Won Jae, Holman, Nicola A., Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2002). Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Molecular Carcinogenesis, 34 (4), 165-171. doi: 10.1002/mc.10061

Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231

2002

Journal Article

Evaluating Australia's National Medicines Policy using geographical mapping

Roughead, E. E., Monteith, G. R., Harvey, K. J. and Tett, S. E. (2002). Evaluating Australia's National Medicines Policy using geographical mapping. Internal Medicine Journal, 32 (3), 66-71. doi: 10.1046/j.1445-5994.2002.00166.x

Evaluating Australia's National Medicines Policy using geographical mapping

2002

Conference Publication

www.qummap.health.gov.au: What's happening where? Who's involved? What's missing?

Roughead, E. E., Monteith, G. R. and Tett, S.E. (2002). www.qummap.health.gov.au: What's happening where? Who's involved? What's missing?. National Medicines Symposium 2002, Canberra, 20-22 March 2002. Canberra: NPS.

www.qummap.health.gov.au: What's happening where? Who's involved? What's missing?

2002

Conference Publication

P/Q and L-type calcium channel blockers abolish morphine-3-glucuronide (M3G)-induced indirect activation of the NMDA receptor

Hemstapat, K., Monteith, G. R. and Smith, M. T. (2002). P/Q and L-type calcium channel blockers abolish morphine-3-glucuronide (M3G)-induced indirect activation of the NMDA receptor. AHMR Congress 2002, Melbourne, 24-29 Nov. 2002. Melbourne: NHMRC.

P/Q and L-type calcium channel blockers abolish morphine-3-glucuronide (M3G)-induced indirect activation of the NMDA receptor

2002

Conference Publication

Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures

Smith, S. A., Monteith, G. R. and Roberts-Thomson, S. J. (2002). Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures. Neuroscience 2002, Florida, 2-7 Nov. 2002. Washington, DC: ScholarOne.

Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures

2002

Conference Publication

Expression and function of the peroxisome proliferator-activated receptor in human breast cancer cell lines.

Roberts-Thomson, S. J., May, F. J., Suchanek, K. M., Lee, W.J., Holman, N. A. and Monteith, G. R. (2002). Expression and function of the peroxisome proliferator-activated receptor in human breast cancer cell lines.. American Association for Cancer Research 93rd Annual Meeting, San Francisco, 6-10 Apr. 2002. Linthicum, USA: Cadmus.

Expression and function of the peroxisome proliferator-activated receptor in human breast cancer cell lines.

2002

Conference Publication

Investigation of the role of dynorphin-A in mediating morphine-3-glucuronide's neuro-excitatory effects

Hemstapat, K., Monteith, G. R. and Smith, M. T. (2002). Investigation of the role of dynorphin-A in mediating morphine-3-glucuronide's neuro-excitatory effects. 10th World Congress on Pain, San Diego, 17-22 Aug. 2002. Seattle: IASP Press.

Investigation of the role of dynorphin-A in mediating morphine-3-glucuronide's neuro-excitatory effects

2002

Conference Publication

The plasma membrane Ca2+ ATPase in breast cancer cell lines

Monteith, G. R., Lee, W.J., Holman, N. A., May, F. J., Lehrbach, G.M. and Roberts-Thomson, S. J. (2002). The plasma membrane Ca2+ ATPase in breast cancer cell lines. American Association for Cancer Research 93rd Annual Meeting, San Francisco, 6-10 Apr. 2002. Linthicum, USA: Cadmus.

The plasma membrane Ca2+ ATPase in breast cancer cell lines

2001

Conference Publication

Evaluation of the neurotoxic effects of morphine-3-glucuronide (M3G) in neuronal cultures.

Hemstapat, K., Smith, S. A., Monteith, G. R. and Smith, M. T. (2001). Evaluation of the neurotoxic effects of morphine-3-glucuronide (M3G) in neuronal cultures.. Annual Conference of APSA, Melbourne, 24-27 Nov 2001. Melbourne: APSA.

Evaluation of the neurotoxic effects of morphine-3-glucuronide (M3G) in neuronal cultures.

Current funding

  • 2026 - 2027
    Advancing a first-in-class therapy for the treatment of advanced and refractory prostate cancer
    NHMRC Development Grant
    Open grant
  • 2025 - 2028
    A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy
    United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
    Open grant
  • 2023 - 2027
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2026
    An active ion transport pathway exploited by coronaviruses
    ARC Discovery Projects
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2020 - 2024
    Deciphering and intercepting messages between cancer cells and cells in the breast cancer microenvironment: Roles for intracellular calcium signaling
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2020 - 2023
    A recently identified calcium channel provides diverse opportunities for pharmacotherapy in breast cancer
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Exploiting remodelling of calcium signalling to specifically target triple negative breast cancer via promotion of apoptosis
    Cancer Council Queensland
    Open grant
  • 2018 - 2024
    Australian Red Cross Blood Service Chair in Donor Behaviour
    Australian Red Cross Blood Service
    Open grant
  • 2018 - 2021
    Calcium cycling and heat generation in skeletal muscle fibres
    ARC Discovery Projects
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Pharmacological targeting of an adaptive breast cancer cell survival pathway as a novel treatment for breast cancer: Constitutive Ca2+ influx mechanisms in triple negative breast cancer cells
    Cancer Council Queensland
    Open grant
  • 2017 - 2021
    Exploiting the Remodeling of Ca2+ Signaling in Breast Cancer Cell Microenvironments to Control Metastasis and to Specifically Target Brain Metastases
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2015 - 2021
    Collaborative Grants between WMHHS and University of Queensland
    West Moreton Hospital and Health Service
    Open grant
  • 2015 - 2017
    Exploiting the overexpression of a specific calcium permeable ion channel in breast cancer cells: a new pharmacological approach to targeting breast cancer.
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Resistance to Herceptin (trastuzumab) in HER2 positive breast cancers: the role of calcium signalling
    NHMRC Project Grant
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    QUE ORAI1 PROJECT
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    Identification and characterisation of calcium signalling modifying proteins as drug targets for basal breast cancer
    Cancer Council Queensland
    Open grant
  • 2012 - 2015
    Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment
    NHMRC Development Grant
    Open grant
  • 2011
    Establishment of a robotic liquid handling platofrm for the use of 384 and 1536 well plates
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    High content imaging analysis for bioactive and novel therapeutic target evaluation
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Multiphoton microscopy of living animals as a tool for immunology and cell biology studies
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2009
    A core pharmacy facility for molecular biology, expression and protein post translational modification studies in cancer, cardiovascular, pain and epilepsy research
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2012
    Calcium Influx Pathways and Breast Cancer
    NHMRC Project Grant
    Open grant
  • 2009
    Robotics Instrumentation for High Throughput Sample preparation for Increased Productivity of the CIPDD/TetraQ's HPLC-MS/MS Systems for Quantitative Analysis of Organics in a Quality Systems NATA-Acc
    UQ Faculty Co-Funding
    Open grant
  • 2009 - 2011
    Secretory pathway calcium regulation and breast cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2011
    Nutritional properties of mango fruits: linking plant genomics to cellular bioactivities
    ARC Linkage Projects
    Open grant
  • 2008 - 2010
    Partnerships in Health Research Collaborative Challenge - Pick your Partners!
    Cancer Bequest Fund
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2006 - 2007
    Calcium transporters and breast cancer: exploiting the link for new pharmaceutically relevant drug targets.
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2008
    Identification of nutritional bioactives in tropical fruit
    ARC Linkage Projects
    Open grant
  • 2005
    Establishment of an improved model of relapsing MS and the characterisation of the role of Peroxisome Proliferator - activated receoptors alpha and beta
    Multiple Sclerosis Research Australia
    Open grant
  • 2005
    Ethanol, PPARb and Breast Cancer
    Australian Brewers' Foundation
    Open grant
  • 2005
    NHMRC_Equipment Grant = DSI Telemetry System
    NHMRC Equipment Grant
    Open grant
  • 2005
    Uncharacterized Calcium Transporters as Targets for Disease: Training of a Pharmacy Student in Drug Target Identification and Characterization
    Pharmaceutical Society of Australia
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2004
    PPARb In Breast Cancer: Gene Transcription And Molecular Mechanisms
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2004
    Role Of Plasma Membrane Ca Pump In High Glucose Induced Changes In Ca Signalling
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2003 - 2004
    Assessment of Ca2+ levels in subcellular organelles and the activity of Ca2+ efflux pathways using fluorescence didgital imaging techniques: Application to high throughput screening
    Society for Biomolecular Screening
    Open grant
  • 2003
    Development of high-throughput assays for the identification of novel anticancer agents.
    Pharmaceutical Society of Australia
    Open grant
  • 2003
    Malvern Zetasizer 3000HS
    NHMRC Equipment Grant
    Open grant
  • 2003
    Unprecedented Alkaloid Hybrids that Selectively Modulate Various Cancers and the Central Nervous System
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Funding for molecular biology computer software
    Brain Research Fund
    Open grant
  • 2002 - 2003
    Pharmacological investigation of the toxicological effects of high doses of systemic morphine
    Queensland Cancer Fund
    Open grant
  • 2002 - 2003
    The plasma membrane calcium ATPase (PMCA) in breast tumorigenic cells
    Queensland Cancer Fund
    Open grant
  • 2001 - 2002
    NHMRC Equipment Grant 2000
    NHMRC Equipment Grant
    Open grant
  • 2001
    A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase
    Brain Research Fund
    Open grant
  • 2001
    Partial funding to purchase a Biohazard II laminar flow hood.
    Pharmaceutical Society of Australia
    Open grant
  • 2001
    The plasma membrane Ca2+-ATPase (PMCA) in human mammary gland tumorigenesis
    Cancer Bequest Fund
    Open grant
  • 2000 - 2001
    Characterisation of peroxisome proliferator-activated receptors (PPARs) in neurons: are PPARs regulators of neuronal survival with roles in dementia and Alzheimer's disease.
    RL Cooper Medical Research Foundation Limited
    Open grant
  • 2000 - 2002
    The plasmalemmal calcium pump and vascular smooth muscle cell proliferation
    NHMRC Project Grant
    Open grant
  • 2000
    The regulation of mitochondrial calcium in tumorigenic and non-tumorigenic breast epithelial cells
    Pharmaceutical Society of Australia
    Open grant
  • 2000
    What are the consequences of plasma membrane calcium pump inhibition? implications for calcium homeostasis, proliferation and apoptosis.
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of plasma membrane calcium pump isoforms in vascular smooth muscle cells
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of the plasma membrane calcium pump during hypoxia and ischemia
    Pharmaceutical Society of Australia
    Open grant
  • 1999
    PPAR and neurotoxicity
    Brain Research Fund
    Open grant
  • 1999 - 2001
    The plasma membrane calcium pump as a target for inhibition by tyrosine kinase phosphorylation: implications for cardiovascular disease
    National Heart Foundation of Australia
    Open grant
  • 1999
    The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine
    Ramaciotti Foundation
    Open grant
  • 1999
    Travel costs to neurosciences meeting 1999
    Potter Foundation
    Open grant
  • 1998
    Regulation of calcium pumps in smooth muscle
    Pharmaceutical Society of Australia
    Open grant

Availability

Professor Gregory Monteith is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • Calcium signalling pathways in cancer progression

  • Calcium signalling changes associated with viral infection

  • Calcium channels and pumps as drug targets

  • Design of innovative high throughput methods for drug screening and testing

Supervision history

Current supervision

  • Doctor Philosophy

    Development of novel methods to identify calcium channels and pumps as drug targets in diseases.

    Principal Advisor

    Other advisors: Dr Melanie Robitaille

  • Doctor Philosophy

    Calcium-mediated Signaling Pathways in Breast Cancer

    Principal Advisor

    Other advisors: Dr Melanie Robitaille

  • Doctor Philosophy

    The intersection between calcium signaling and coronavirus infection

    Associate Advisor

    Other advisors: Dr Larisa Labzin, Dr Melanie Robitaille

  • Doctor Philosophy

    Development of a new approach to target exosomes for cancer treatment

    Associate Advisor

    Other advisors: Associate Professor Sherry Wu

Completed supervision

Enquiries

For media enquiries about Professor Gregory Monteith's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au